“Brain doctors will stop the practice of prescribing controlled substances as ADHD treatment, such as Adderall and Ritalin for new patients, effective Monday, May 9,” CEO Kyle Robertson wrote in the blog post. memorandum, which has also been published online. “Over the course of the next few months, existing patients will continue to receive their clinically appropriate prescription drugs and the company will add additional tools for physicians to further protect this practice.”
.
